WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'7101 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 18'5851 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 1'249  1'244  1'240  1'235  1'231  1'185  1'056  966 
Births 14  14  14  14  15  20  22  22 
Surviving infants 14  14  14  14  14  20  22  22 
Pop. less than 5 years 71  70  70  71  75  99  98  109 
Pop. less than 15 years 242  246  249  254  260  305  306  344 
Female 15-49 years 328  329  330  331  331  337  295  255 

Number of reported case

(Click for retrospective incidence data for Mauritius)
Diphtheria
Japanese encephalitis
Measles 12  35 
Mumps 14  11 
Pertussis 12 
Polio*
Rubella 10 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mauritius)
Vaccine year result method % card seen                                                
BCG 1984  98  EPI   94  97  99  99  99  99  88  87  89 
DTP1 1984  93  EPI   94  97  99  99  99  99  88 
DTP3 1984  89  EPI   94  97  98  98  98  99  88  85  89 
DTP4          90 
IPV1         
HepB_BD          88 
HepB3          97  98  98  98  99  88 
Hib3          97  98  98  98  99 
JapEnc         
MCV1          98  99  99  99  99  84  76 
MCV2          85  85  90  89  90 
PCV1         
PCV3         
Pol3 1984  89  EPI   94  98  98  98  98  99  88  86  90 
Rota1         
Rota_last         
Rubella1          98  99  99  99  99 
TT2plus          85  85  95  95  96  76  58 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mauritius)
BCG 97  99  99  99  99  88  87  89 
DTP1 97  99  99  99  99  88  95  96 
DTP3 97  98  98  98  99  88  85  89 
HepB3 97  98  98  98  99  88 
HepB_BD
Hib3 97  98  98  98  99 
MCV1 98  99  99  99  99  84  76 
MCV2 85  85  90  89  90 
PAB 95  95  95  95  95  79  61 
PCV3
Pol3 98  98  98  98  99  88  86  90 
Rota_last

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 30
From 80 to 89% 70
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DT 18 months; 5 years; Yes
DTaPHib 6, 10, 14 weeks; 18 months; Yes
HepB 6, 10, 14 weeks; Yes workers at risk, dialysis patients, travelers
IPV 6, 10, 14 weeks; 18 months; Yes babies born to HIV positive mothers
Influenza 6months to 2 years; >= 60 years; Yes chronic illness, pregnant women, health care workers, Haj and other travellers and airport staff
MMR 12 months; 5 years; Yes
MenACWY Yes Travelers
OPV 6, 10, 14 weeks; 18 months; Yes
TT Yes pregnant women, injured persons
Typhoid Yes Travelers
YF Yes Travelers

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number   10  10  10  10 

System performance

Total Nº districts in country number 10  10  10  10  10  10  10 
Nº districts with DTP3 coverage >=80% number 10  10  10  10  10  10  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 30  30  30  10 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     100  100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.